[O-03] Oral Session 03 Neuroimmunology1

[O-03-3] Iguratimod improves a secondary progressive multiple sclerosis model by therapeutic administration

^○Satoshi Nagata¹, Ryo Yamasaki¹, Yuko Nakamuta¹, Ezgi Ozdemir¹, Hiroo Yamaguchi¹, Katsuhisa Masaki¹, Jun-ichi Kira^2,3 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Translational Neuroscience Center, Graduate School of Medicine, and School of Pharmacy at Fukuoka, International University of Health and Welfare, 3.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital)